Inhibitex's IPO

Inhibitex raised a round of funding on June 11, 2004. Investors include Public.

Inhibitex is a biopharmaceutical company that is pursuing the development and commercialization of products for the infectious disease market. Inhibitex has a proprietary technology platform that util…

Articles about Inhibitex's IPO: